Warp Sciences
Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.
$215MSeries A
LeadL
Lightspeed
Activity from announced rounds
Activity in this selectionBiotech
Lightspeed Venture Partners invests from seed through growth in enterprise, consumer, fintech and healthcare companies, with a global investment platform.
Its sector teams approach different company-building problems: enterprise adoption, changes in consumer behaviour, financial infrastructure and unmet clinical needs. The partnership includes former founders and operators with domain experience, so the relevant team depends on the business being built rather than a single firm-wide industry thesis.
Lightspeed’s healthcare practice focuses on technologies that can improve patient outcomes. In fintech, its stated interests span the financial technology stack, including blockchain, rather than being limited to consumer banking applications.
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $778M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionEnveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantTriomics
Building AI infrastructure to turn complex cancer records into structured intelligence
$22MSeries B
Role not disclosedScience Corporation
Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases
$230MSeries C
Role not disclosed